Activation of the Tumor Suppressor PP2A Emerges as a Potential Therapeutic Strategy for Treating Prostate Cancer

Protein phosphatase 2A (PP2A) is a tumor suppressor complex that has recently been reported as a novel and highly relevant molecular target in prostate cancer (PCa). However, its potential therapeutic value remains to be fully clarified. We treated PC-3 and LNCaP cell lines with the PP2A activators...

Descripción completa

Detalles Bibliográficos
Autores principales: Cristóbal, Ion, González-Alonso, Paula, Daoud, Lina, Solano, Esther, Torrejón, Blanca, Manso, Rebeca, Madoz-Gúrpide, Juan, Rojo, Federico, García-Foncillas, Jesús
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4483628/
https://www.ncbi.nlm.nih.gov/pubmed/26023836
http://dx.doi.org/10.3390/md13063276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4483628/
https://www.ncbi.nlm.nih.gov/pubmed/26023836
http://dx.doi.org/10.3390/md13063276

Ejemplares similares